Trial Profile
A Multi-Center, Double-Randomized, Double Blind, Placebo Controlled Study to Evaluate the Analgesic Efficacy and Safety of Intravenous CR845 Dosed Preoperatively and Postoperatively in Patients Undergoing a Laparoscopic Hysterectomy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2016
Price :
$35
*
At a glance
- Drugs Difelikefalin (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Cara Therapeutics
- 10 Mar 2016 According to a Cara Therapeutics media release, data from this study were presented at the American Society of Health-System Pharmacists (ASHP) 2015 Midyear Clinical Meeting.
- 01 Dec 2015 Postoperative nausea and vomiting results will be presented at the American Society of Health-System Pharmacists (ASHP) 2015 Midyear Clinical Meeting, according to a Cara Therapeutics media release.
- 19 Oct 2015 According to a Cara Therapeutics media release, data from this study will be presented at the American Society of Anesthesiologists' annual meeting 2015.